Influence of NMDA and non-NMDA antagonists on acute and inflammatory pain in the trigeminal territory: A placebo control study

Arquivos de Neuro-Psiquiatria

Volumn 66, Issue 4, 2008, Pages 837-843

  Piovesan, Elcio Juliato ^a   Randunz, Vitor ^a   Utiumi, Marco ^a   Lange, Marcos Cristiano ^a   Kowacs, Pedro André ^a   Mulinari, Rogério Andrade ^a   Oshinsky, Michael ^b   Vital, Maria ^a   Sereniki, Adriana ^a   Fernandes, Artur Furlaneto ^a   Silva, Lucas Leite ^a   Werneck, Lineu César ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Divalproex; Formalin test; Memantine; NMDA and non NMDA receptors; Topiramate

Indexed keywords

FORMALDEHYDE; ISOTONIC SOLUTION; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; TOPIRAMATE; VALPROATE SEMISODIUM;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; IMMOBILIZATION; LOCOMOTION; MALE; MOTOR PERFORMANCE; MOVEMENT (PHYSIOLOGY); NOCICEPTION; NONHUMAN; OPEN FIELD BEHAVIOR; PAIN; RAT; REARING;

EID: 58149232926     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2008000600012     Document Type: Article

References (35)

1. Jeftinija S. Excitatory transmission in the dorsal horn is in part mediated through APV-sensitive NMDA receptors. Neurosci Lett 1989;96:191-196.
2. Tallaksen-Greene SJ, Young AB, Penney JB, Beitz AJ. Excitatory amino acid bindings sites in the trigeminal principal sensory and spinal trigeminal nuclei of the rat. Neurosci Lett 1992;141:79-83.
3. Watanabe M, Mishina M, Inoue Y. Distinct gene expression of the N-methyl-D-aspartate receptor channel subunit in peripheral neurons of the mouse sensory ganglia and adrenal gland. Neurosci Lett 1994;165:183-186.
4. Mayer ML, Westbrook GL. Permeation and block of N-Methyl-D-aspartic acid receptors channels by divalent cations in mouse cultured central neurones. J Physiol 1987;394:501-527.
5. Liu H, Mantyh PW, Basbaum AI. NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature 1997;386:721-724.
6. Zhou S, Bonasera L, Carlton SM. Peripheral administration of NMDA, AMPA or KA results in pain behaviors in rats. Neuroreport 1996;22:895-900.
7. Terayama R, Guan Y, Dubner R, Ren K. Activity-induced plasticity in brain stem pain modulatory circuitry after inflammation. Neuroreport 2000;11:1915-1919.
8. Woolf CJ. Windup and central sensitization are not equivalent. Pain 1996;66:105-108.
9. Coderre TJ, Melzack R. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 1992;12:3665-3670.
10. Schneiderman JH. Topiramate: pharcokinetics and pharmacodynamics. Can J Neurol Sci 1998;25:S3-S5.
11. Medvedev IO, Malyshkin AA, Belozertseva IV, et al. Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain. Neurophamacology 2004;47:175-183.
12. Kovács G, Kocsis P, Tarnawa I, Horváth C, Szombathelyi Z, Farkas S. NR2B containing NMDA receptor dependent windup of single spinal neurons. Neuropharmacology 2004;46:23-30.
13. Tan PH, Yang LC, Shih HC, Lan KC, Cheng JT. Gene knockdown with intrathecal siRNA of NMDA receptor NR2B subunit reduces formalin-induced nociception in the rat. Gene Ther 2005;12:59-66.
14. Caudle RM, Perez FM, Del Valle-Pinero AY, Iadarola MJ. Spinal cord NR1 serine phosphorylation and NR2B subunit suppression following peripheral inflammation. Mol Pain 2005;1:25.
15. Chazot PL. The NMDA receptor NR2B subunit: a valid therapeutic target for multiple CNS pathologies. Curr Med Chem 2004;11:389-396.
16. Eisenberg E, Vos BP, Strassman AM. The NMDA antagonist Memantine blocks pain behavior in a rat model of formalin-induced facial pain. Pain 1993;54:301-307.
17. Haley JE, Sullivan AF, Dickenson AH. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res 1990;518:218-226.
18. Gordon SM, Dionne RA, Brahim J, Jabir F, Dubner R. Blockade of peripheral neuronal barrage reduces postoperative pain. Pain 1997;70:209-215.
19. Gottschalk A, Smith DS, Jobes DR et al. Preemptive epidural analgesia and recovery from radical prostatectomy: a randomized controlled trial. JAMA 1998;279:1076-1082.
20. Tverskoy M, Oz Y, Isakson A, Finger J, Bradley EL Jr, Kissin I. Preemptive effect of fentanyl and ketamine on postoperative pain and wound hyperalgesia. Anesth Analg 1994;78:205-209.
21. Omote K, Kawamata T, Kawamata M, Namiki A. Formalin-induced release of excitatory amino acids in the skin of the rat hindpaw. Brain Res 1998;787:161-164.
22. Shu YS, Zhao ZQ. Comparison of NMDA and non-NMDA receptor antagonist-induced inhibition in hindpaw withdrawal response to noxious thermal stimulation. Sheng Li Xue Bao 1998;50:337-340.
23. Danysz W, Parsons CG, Kornhuber J, Schmidt WJ, Quack G. Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents - preclinical studies. Neurosci Biobehav Rev 1997;21:455-468.
24. Brandes JL, Saper JR, Diamond M, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004;291:965-973.
25. Ghose K, Niven B. Prophylactic sodium valproate therapy in patient with drug-resistent migraine. Methods Find Exp Clin Pharmacol 1998;20:353-359.
26. Parsons CG, Danysz W, Quack G. Memantine is clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - a review of preclinical data. Neuropharmacology 1999;38:735-767.
27. Chaplan SR, Malmberg AB, Yaksh TL. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. J Pharmacol Exp Ther 1997;280:829-838.
28. Einsenberg E, LaCross S, Strassman AM. The effects of the clinically tested NMDA receptor antagonist memantine on carageenan-induced thermal hyperalgesia in rats. Eur J Pharmacol 1994;255:123-129.
29. Eisenberg E, LaCross S, Strassman AM. The clinically tested N-methyl-D-aspartate receptor antagonist memantine blocks and reverses thermal hyperalgesia in a rat model of painful mononeuropathy. Neurosci Lett 1995;187:17-20.
30. Carlton SM, Rees H, Gondesen K, Tsuruoka M, Willis WD. Behavioral and electrophysiological effects of memantine in a primate model of peripheral neuropathy. Soc Neurosci Abs 1994;568:18.
31. Davidson EM, Carlton SM. Intraplantar injection of dextrorphan ,ketamine or memantine attenuates formalin-induced behaviors. Brain Res 1998;785:136-42.
32. Alaverdashvili M, Kubová H, Mares P. Motor performance and behavior of immature rats are not compromised by a high dose of topiramate. Epilepsy Behav 2005;7:222-230.
33. Barros HM, Tannhauser SL, Tannhauser MA, Tannhauser M. Effect of sodium valproate on the open-field behavior of rats. Braz J Med Biol Res 1992;25:281-287.
34. Danysz W, Essmann U, Bresink I, Wilke R. Glutamate antagonists have different effects on spontaneous locomotor activity in rats. Pharmacol Biochem Behav 1994;48:111-118.
35. Kos T, Popik P. A comparison of the predictive therapeutic and undesired side-effects of the NMDA receptor antagonist, memantine, in mice. Behav Pharmacol 2005;16:155-161.